Literature DB >> 22280241

Regulatory cross talks of bone cells, hematopoietic stem cells and the nervous system maintain hematopoiesis.

Orit Kollet1, Jonathan Canaani, Alexander Kalinkovich, Tsvee Lapidot.   

Abstract

Adult hematopoietic stem cells (HSC) continuously replenish the blood with immune and blood cells with a finite life span, from the bone marrow (BM) reservoir of immature and maturing leukocytes. Regulation of HSC migration and development is essential for their function and blood cell production. These diverse and multiple states require a tight regulation to efficiently address host defense and repair requirements. Numerous recent studies disclose a central role for bone related cells in regulation of HSC and hematopoiesis. During ontogeny HSC home and seed the fetal BM in the last gestation period when the bone is already ossified. Ossification involves bone forming osteoblast- and bone degrading osteoclast activity and is considered essential for the formation of BM cavities and hematopoiesis. This synchronized association implies the need for active bone cells and bone turnover for HSC regulation. Osteoblastic cells and SDF- 1+/nestin+ reticular adventitial and CAR cells are crucial for regulation of HSC lodgment, self-renewal and function. Bone resorbing osteoclasts regulate bone turnover and progenitor cell detachment and release from the BM. Sympathetic signals from the nervous system activated by circadian rhythms or stress conditions control both bone turnover and HSC migration and development. In this review we discuss pathways and mechanisms involved in this orchestrated regulatory network. A special focus is made on the pivotal role of the SDF-1/CXCR4 axis as a determinant of HSC fate. Inflammation, DNA damage, cytokine mobilization, microgravity and aging are discussed as specific physiologic and pathologic events entailing dysregulation of the tightly balanced Bone-Brain-Blood triad.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280241     DOI: 10.2174/187152812800392760

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  8 in total

1.  Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.

Authors:  Sandhya R Panch; Michael E Bozik; Thomas Brown; Michelle Makiya; Calman Prussin; Donald G Archibald; Gregory T Hebrank; Mary Sullivan; Xiaoping Sun; Lauren Wetzler; JeanAnne Ware; Michael P Fay; Cynthia E Dunbar; Steven I Dworetzky; Paneez Khoury; Irina Maric; Amy D Klion
Journal:  Blood       Date:  2018-05-08       Impact factor: 22.113

Review 2.  Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair.

Authors:  Polina Goichberg
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

3.  3,4-methylenedioxymethamphetamine (MDMA--Ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to Listeria monocytogenes infection in mice.

Authors:  V Ferraz-de-Paula; A Ribeiro; J Souza-Queiroz; M L Pinheiro; J F Vecina; D P M Souza; W M Quinteiro-Filho; R L M Moreau; M L S Queiroz; J Palermo-Neto
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-12       Impact factor: 4.147

4.  A 635-nm light-emitting diode (LED) therapy inhibits bone resorptive osteoclast formation by regulating the actin cytoskeleton.

Authors:  Hyun-Ju Lim; Man-Seok Bang; Hye-Min Jung; Jang-In Shin; Gae-Sig Chun; Chung-Hun Oh
Journal:  Lasers Med Sci       Date:  2013-06-30       Impact factor: 3.161

Review 5.  Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes.

Authors:  Regina P Markus; Pedro A Fernandes; Gabriela S Kinker; Sanseray da Silveira Cruz-Machado; Marina Marçola
Journal:  Br J Pharmacol       Date:  2017-12-15       Impact factor: 8.739

6.  Dynamic Cross Talk between S1P and CXCL12 Regulates Hematopoietic Stem Cells Migration, Development and Bone Remodeling.

Authors:  Karin Golan; Orit Kollet; Tsvee Lapidot
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-23

7.  Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches.

Authors:  Barbara Breznik; Clara Limbaeck Stokin; Janko Kos; Mohammed Khurshed; Vashendriya V V Hira; Roman Bošnjak; Tamara T Lah; Cornelis J F Van Noorden
Journal:  J Mol Histol       Date:  2018-07-25       Impact factor: 2.611

Review 8.  RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis.

Authors:  Armin Zebisch; Veronica Caraffini; Heinz Sill
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.